Although the putative role of GSK3β in cancer is still debated [79,80], the overall results indicate that aberrant expression and activity of GSK3β is likely to be a common and fundamental characteristic of a broad spectrum of cancers (Figure 3) [78]. This evidence concerns the gene GSK3B and cancer.